Company Filing History:
Years Active: 2015-2017
Title: Innovations of See-Lok Ho in Alzheimer's Disease Research
Introduction
See-Lok Ho is a prominent inventor based in Hong Kong, CN, known for his contributions to the field of pharmaceuticals and chemical industries. He has been instrumental in developing innovative methods for addressing Alzheimer's disease through his research and inventions. With a total of 4 patents, his work focuses on imaging and preventing the aggregation of beta-amyloid peptides, which are crucial in the pathology of Alzheimer's disease.
Latest Patents
One of See-Lok Ho's latest patents is titled "Imaging beta-amyloid peptides aggregation." This invention relates to methods for labeling, imaging, and detecting beta-amyloid (Aβ) peptides, oligomers, and fibrils both in vitro and in vivo. The method utilizes modified carbazole-based fluorophores for magnetic resonance and fluorescence imaging. Additionally, it presents a novel approach to reducing and preventing the aggregation of beta-amyloid peptides, which is vital for treating and preventing Alzheimer's disease. Another significant patent is "Imaging beta-amyloid peptides and inhibition of beta-amyloid peptide aggregation." This invention also focuses on the use of carbazole-based fluorophores for imaging and detecting beta-amyloid peptides, further contributing to the understanding and treatment of Alzheimer's disease.
Career Highlights
See-Lok Ho is affiliated with Hong Kong Baptist University, where he conducts his research and develops his innovative solutions. His work has garnered attention in the scientific community, particularly for its potential impact on Alzheimer's disease treatment.
Collaborations
Throughout his career, See-Lok Ho has collaborated with notable colleagues, including Di Xu and Chung-Yan Poon. These collaborations have enhanced the scope and depth of his research, leading to significant advancements in the field.
Conclusion
See-Lok Ho's innovative contributions to Alzheimer's disease research through his patents and collaborations highlight his commitment to advancing medical science. His work not only provides valuable insights into the pathology of Alzheimer's disease but also offers potential therapeutic solutions for those affected by this condition.